These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Update on SARS-CoV-2 seroprevalence: regional and worldwide. Rostami A; Sepidarkish M; Fazlzadeh A; Mokdad AH; Sattarnezhad A; Esfandyari S; Riahi SM; Mollalo A; Dooki ME; Bayani M; Nazemipour M; Mansournia MA; Hotez PJ; Gasser RB Clin Microbiol Infect; 2021 Dec; 27(12):1762-1771. PubMed ID: 34582980 [TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441 [TBL] [Abstract][Full Text] [Related]
24. Severe acute respiratory syndrome-coronavirus-2 seroprevalence study in Pimpri-Chinchwad, Maharashtra, India coinciding with falling trend - Do the results suggest imminent herd immunity? Banerjee A; Gaikwad B; Desale A; Jadhav SL; Rathod H; Srivastava K Indian J Public Health; 2021; 65(3):256-260. PubMed ID: 34558487 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of SARS-CoV-2 antibodies among nurses: A systematic review and meta-analysis. He S; Hecimovic A; Matijasevic V; Mai HT; Heslop L; Foster J; Alexander KE; Pal N; Alexandrou E; Davidson PM; Frost SA J Clin Nurs; 2022 Jun; 31(11-12):1557-1569. PubMed ID: 34570947 [TBL] [Abstract][Full Text] [Related]
26. Longitudinal Randomized Cohort Study of SARS-CoV-2 Antibody Seroprevalence in the St. Petersburg Population. Smirnov VS; Lyalina LV; Milichkina AM; Khamitova IV; Zueva EV; Ivanov VA; Zaguzov VS; Totolian AA Viruses; 2022 Apr; 14(5):. PubMed ID: 35632653 [TBL] [Abstract][Full Text] [Related]
27. Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis. Hajissa K; Islam MA; Hassan SA; Zaidah AR; Ismail N; Mohamed Z Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742506 [TBL] [Abstract][Full Text] [Related]
28. Seroprevalence of anti-SARS-CoV-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in Salvador, Brazil. Santos CC; de M Lima FW; Magno L; Soares F; Ferraz D; Grangeiro A; Zucchi EM; Préau M; Mabire X; Matos HRSS; Dourado I; BMC Public Health; 2023 Jan; 23(1):61. PubMed ID: 36624484 [TBL] [Abstract][Full Text] [Related]
29. Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis. Jahan N; Brahma A; Kumar MS; Bagepally BS; Ponnaiah M; Bhatnagar T; Murhekar MV Int J Infect Dis; 2022 Mar; 116():59-67. PubMed ID: 34968773 [TBL] [Abstract][Full Text] [Related]
30. Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: Systematic review. Byambasuren O; Dobler CC; Bell K; Rojas DP; Clark J; McLaws ML; Glasziou P PLoS One; 2021; 16(4):e0248946. PubMed ID: 33798211 [TBL] [Abstract][Full Text] [Related]
31. Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil. Amorim Filho L; Szwarcwald CL; Mateos SOG; Leon ACMP; Medronho RA; Veloso VG; Lopes JIF; Porto LCMS; Chieppe A; Werneck GL; Rev Saude Publica; 2020; 54():69. PubMed ID: 32638883 [TBL] [Abstract][Full Text] [Related]
33. Seroprevalence of SARS-CoV-2 antibodies in the general population of Oman: results from four successive nationwide sero-epidemiological surveys. Al-Abri SS; Al-Wahaibi A; Al-Kindi H; Kurup PJ; Al-Maqbali A; Al-Mayahi Z; Al-Tobi MH; Al-Katheri SH; Albusaidi S; Al-Sukaiti MH; Al Balushi AYM; Abdelgadir IO; Al-Shehi N; Morkos E; Al-Maani A; Al-Rawahi B; Alyaquobi F; Alqayoudhi A; Al-Harthy K; Al-Khalili S; Al-Rashdi A; Al-Shukri I; Al Ghafri TS; Al-Hashmi F; Al Jassasi SM; Alshaqsi N; Mitra N; Al Aamry HS; Shah P; Al Marbouai HH; Al Araimi AH; Kair IM; Al Manji AM; Almallak AS; Al Alawi FK; Vaidya V; Muqeetullah M; Alrashdi H; Al Jamoudi SSN; Alshaqsi A; Al Sharji A; Al Shukeiri H; Al-Abri B; Al-Rawahi S; Al-Lamki SH; Al-Manji A; Al-Jardani A Int J Infect Dis; 2021 Nov; 112():269-277. PubMed ID: 34601146 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021. Tunheim G; Rø GØI; Chopra A; Aase A; Kran AB; Vaage JT; Lund-Johansen F; Hungnes O Influenza Other Respir Viruses; 2022 Nov; 16(6):1004-1013. PubMed ID: 35770841 [TBL] [Abstract][Full Text] [Related]
35. Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia. Alharbi NK; Alghnam S; Algaissi A; Albalawi H; Alenazi MW; Albargawi AM; Alharbi AG; Alhazmi A; Al Qarni A; Alfarhan A; Zowawi HM; Alhatmi H; Alghamdi J; Alroqi F; Batarfi K; Arabi YM; Hashem AM; Bosaeed M; Aldibasi O J Infect Public Health; 2021 Jul; 14(7):832-838. PubMed ID: 34118732 [TBL] [Abstract][Full Text] [Related]
36. The Seroprevalence of SARS-CoV-2 in Children During Early COVID-19 Pandemic in Korea: A Nationwide, Population-Based Study. Lee J; Choe YJ; Minn D; Kim JH J Korean Med Sci; 2022 Nov; 37(44):e314. PubMed ID: 36377292 [TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Stringhini S; Wisniak A; Piumatti G; Azman AS; Lauer SA; Baysson H; De Ridder D; Petrovic D; Schrempft S; Marcus K; Yerly S; Arm Vernez I; Keiser O; Hurst S; Posfay-Barbe KM; Trono D; Pittet D; Gétaz L; Chappuis F; Eckerle I; Vuilleumier N; Meyer B; Flahault A; Kaiser L; Guessous I Lancet; 2020 Aug; 396(10247):313-319. PubMed ID: 32534626 [TBL] [Abstract][Full Text] [Related]
38. Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021. Ssuuna C; Galiwango RM; Kankaka EN; Kagaayi J; Ndyanabo A; Kigozi G; Nakigozi G; Lutalo T; Ssekubugu R; Wasswa JB; Mayinja A; Nakibuuka MC; Jamiru S; Oketch JB; Muwanga E; Chang LW; Grabowski MK; Wawer M; Gray R; Anderson M; Stec M; Cloherty G; Laeyendecker O; Reynolds SJ; Quinn TC; Serwadda D BMC Infect Dis; 2022 Feb; 22(1):174. PubMed ID: 35189840 [TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 Seroprevalence in Children from Western Romania, March to June 2021. Olariu TR; Craciun AC; Vlad DC; Dumitrascu V; Pop LL; Horhat F; Lupu MA Vector Borne Zoonotic Dis; 2022 Apr; 22(4):267-270. PubMed ID: 35384727 [TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study. Beaumont A; Durand C; Ledrans M; Schwoebel V; Noel H; Le Strat Y; Diulius D; Colombain L; Médus M; Gueudet P; Mouly D; Aumaître H BMJ Open; 2021 Nov; 11(11):e053201. PubMed ID: 34815286 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]